{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:08:25Z","timestamp":1767654505488,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["#2092, IR.PII.REC.1401.022"],"award-info":[{"award-number":["#2092, IR.PII.REC.1401.022"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41429-025-00870-3","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:56:35Z","timestamp":1760583395000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Olorofim, a potential novel drug candidate against Helicobacter pylori infection"],"prefix":"10.1038","volume":"79","author":[{"given":"Saba","family":"Ghaffari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Prim. 2023;9:19.","journal-title":"Nat Rev Dis Prim"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"1257817","DOI":"10.3389\/fcimb.2023.1257817","volume":"13","author":"Q Sun","year":"2023","unstructured":"Sun Q, Yuan C, Zhou S, Lu J, Zeng M, Cai X, et al. Helicobacter pylori infection: a dynamic process from diagnosis to treatment. Front Cell Infect Microbiol. 2023;13:1257817.","journal-title":"Front Cell Infect Microbiol"},{"key":"870_CR3","first-page":"1","volume":"61","author":"I Schistosomes","year":"1994","unstructured":"Schistosomes I. liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1\u2013241.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018;155:1372\u201382.e17.","journal-title":"Gastroenterology"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"e12628","DOI":"10.1111\/hel.12628","volume":"24","author":"N Salehi","year":"2019","unstructured":"Salehi N, Attaran B, Eskini N, Esmaeili M, Sharifirad A, Sadeghi M, et al. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: a molecular docking study of prevalent GyrA mutations. Helicobacter. 2019;24:e12628.","journal-title":"Helicobacter"},{"key":"870_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00438-0","volume":"13","author":"B Attaran","year":"2021","unstructured":"Attaran B, Salehi N, Ghadiri B, Esmaeili M, Kalateh S, Tashakoripour M, et al. The penicillin binding protein 1\u2009A of Helicobacter pylori, its amoxicillin binding site and access routes. Gut Pathog. 2021;13:43.","journal-title":"Gut Pathog"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"e12731","DOI":"10.1111\/hel.12731","volume":"25","author":"N Salehi","year":"2020","unstructured":"Salehi N, Attaran B, Zare-Mirakabad F, Ghadiri B, Esmaeili M, Shakaram M, et al. The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains. Helicobacter. 2020;25:e12731.","journal-title":"Helicobacter"},{"key":"870_CR8","unstructured":"Organisation WH. WHO publishes list of bacteria for which new antibiotics are urgently needed Geneva: World Heath Organisation; 2017 [Available from: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"33373","DOI":"10.1074\/jbc.M004451200","volume":"275","author":"RA Copeland","year":"2000","unstructured":"Copeland RA, Marcinkeviciene J, Haque TS, Kopcho LM, Jiang W, Wang K, et al. Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem. 2000;275:33373\u20138.","journal-title":"J Biol Chem"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1021\/jm020112w","volume":"45","author":"TS Haque","year":"2002","unstructured":"Haque TS, Tadesse S, Marcinkeviciene J, Rogers MJ, Sizemore C, Kopcho LM, et al. Parallel synthesis of potent, pyrazole-based inhibitors of helicobacter pylori Dihydroorotate dehydrogenase. J Med Chem. 2002;45:4669\u201378.","journal-title":"J Med Chem"},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1248\/cpb.c17-00796","volume":"66","author":"T Ohishi","year":"2018","unstructured":"Ohishi T, Inaoka DK, Kita K, Kawada M. Dihydroorotate dehydrogenase as a target for the development of novel Helicobacter pylori-specific antimicrobials. Chem Pharm Bull. 2018;66:239\u201342.","journal-title":"Chem Pharm Bull"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"e12470","DOI":"10.1111\/hel.12470","volume":"23","author":"T Ohishi","year":"2018","unstructured":"Ohishi T, Masuda T, Abe H, Hayashi C, Adachi H, Ohba SI, et al. Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection. Helicobacter. 2018;23:e12470.","journal-title":"Helicobacter"},{"key":"870_CR13","unstructured":"Politi K. F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US Manchester (UK): F2G Ltd; 2024 [Available from: https:\/\/f2g.com\/press-release\/f2g-announces-100-million-financing-to-advance-late-stage-development-and-commercialization-of-novel-antifungal-drug-candidate-olorofim-in-the-us\/."},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"12809","DOI":"10.1073\/pnas.1608304113","volume":"113","author":"JD Oliver","year":"2016","unstructured":"Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, et al. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci USA. 2016;113:12809\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2672.1994.tb03036.x","volume":"77","author":"G Mendz","year":"1994","unstructured":"Mendz G, Jimenez B, Hazell S, Gero A, O\u2019Sullivan W. De novo synthesis of pyrimidine nucleotides by Helicobacter pylori. J Appl Bacteriol. 1994;77:1\u20138.","journal-title":"J Appl Bacteriol"},{"key":"870_CR16","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. EUCAST Clinical Breakpoint Table Sweden: European Committee on Antimicrobial Susceptibility Testing; 2015 [Available from: https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-62703-005-2_26","volume":"921","author":"M Mohammadi","year":"2012","unstructured":"Mohammadi M, Kashani SS, Garoosi YT, Tazehkand SJ. In vivo measurement of Helicobacter pylori infection. Methods Mol Biol. 2012;921:239\u201356.","journal-title":"Methods Mol Biol"},{"key":"870_CR18","unstructured":"CLSI. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 10th ed. CLSI standard M07-A10. Wayne, PA: Clinical and Laboratory Standards Institute; 2015."},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"e8704","DOI":"10.5812\/jjm.8704","volume":"7","author":"J Faghri","year":"2014","unstructured":"Faghri J, Poursina F, Moghim S, Esfahani HZ, Esfahani BN, Fazeli H, et al. Morphological and bactericidal effects of different antibiotics on Helicobacter pylori. Jundishapur J Microbiol. 2014;7:e8704.","journal-title":"Jundishapur J Microbiol"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/jof8101004","volume":"8","author":"LP Borba-Santos","year":"2022","unstructured":"Borba-Santos LP, Rollin-Pinheiro R, da Silva Fontes Y, Dos Santos GMP, de Sousa Ara\u00fajo GR, Rodrigues AM, et al. Screening of pandemic response box library reveals the high activity of olorofim against pathogenic Sporothrix species. Fungi. 2022;8:1004.","journal-title":"Fungi"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/22221751.2022.2034485","volume":"11","author":"JB Buil","year":"2022","unstructured":"Buil JB, Oliver JD, Law D, Baltussen T, Zoll J, Hokken MWJ, et al. Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance. Emerg Microbes Infect. 2022;11:703\u201314.","journal-title":"Emerg Microbes Infect"},{"key":"870_CR22","doi-asserted-by":"crossref","unstructured":"Wiederhold NP. Review of the novel investigational antifungal olorofim. J Fungi. 2020;6:122.","DOI":"10.3390\/jof6030122"},{"key":"870_CR23","doi-asserted-by":"crossref","unstructured":"Jorgensen KM, Astvad KMT, Hare RK, Arendrup MC. EUCAST determination of olorofim (F901318) susceptibility of mold species, method validation, and MICs. Antimicrob Agents Chemother. 2018;62:10\u20131128.","DOI":"10.1128\/AAC.00487-18"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2019.08.167","volume":"519","author":"W Liu","year":"2019","unstructured":"Liu W, Shang F, Chen Y, Lan J, Wang L, Chen J, et al. Biochemical and structural analysis of the Klebsiella pneumoniae cytidine deaminase CDA. Biochem Biophys Res Commun. 2019;519:280\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00284-007-9050-3","volume":"56","author":"DA Beck","year":"2008","unstructured":"Beck DA, O\u2019Donovan GA. Pathways of pyrimidine salvage in Pseudomonas and former Pseudomonas: detection of recycling enzymes using high-performance liquid chromatography. Curr Microbiol. 2008;56:162\u20137.","journal-title":"Curr Microbiol"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"673985","DOI":"10.3389\/fimmu.2021.673985","volume":"12","author":"H Buvelot","year":"2021","unstructured":"Buvelot H, Roth M, Jaquet V, Lozkhin A, Renzoni A, Bonetti EJ, et al. Hydrogen peroxide affects growth of S. aureus through downregulation of genes involved in pyrimidine biosynthesis. Front Immunol. 2021;12:673985.","journal-title":"Front Immunol"},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.14309\/ajg.0000000000001246","volume":"116","author":"OP Nyssen","year":"2021","unstructured":"Nyssen OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, Kupcinskas J, Jonaitis L, et al. Adverse event profile during the treatment of Helicobacter pylori: a real-world experience of 22,000 patients from the European registry on H. pylori management (Hp-EuReg). J Am Coll Gastroenterol. 2021;116:1220\u20139.","journal-title":"J Am Coll Gastroenterol"},{"key":"870_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.abb.2017.06.019","volume":"632","author":"RAG Reis","year":"2017","unstructured":"Reis RAG, Calil FA, Feliciano PR, Pinheiro MP, Nonato MC. The dihydroorotate dehydrogenases: past and present. Arch Biochem Biophys. 2017;632:175\u201391.","journal-title":"Arch Biochem Biophys"},{"key":"870_CR29","doi-asserted-by":"publisher","first-page":"e0289441","DOI":"10.1371\/journal.pone.0289441","volume":"18","author":"C Pinder","year":"2023","unstructured":"Pinder C, Lebedinec R, Levine TP, Birch M, Oliver JD. Characterisation of putative class 1\u2009A DHODH-like proteins from Mucorales and dematiaceous mould species. PLoS ONE. 2023;18:e0289441.","journal-title":"PLoS ONE"},{"key":"870_CR30","doi-asserted-by":"crossref","unstructured":"Agarwal AA, Georgiades JD, Dranow DM, Lorimer DD, Edwards T, Barrett KF, et al. Crystal structure of dihydroorotate dehydrogenase from Helicobacter pylori with bound flavin mononucleotide. Struct Biol Cryst Commun. 2025;81:108\u2013117.","DOI":"10.1107\/S2053230X25000858"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00870-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:06:03Z","timestamp":1767654363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00870-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00870-3","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"type":"print","value":"0021-8820"},{"type":"electronic","value":"1881-1469"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}